Evidence map›Paper›PMID 39695952›Full record

ArticleBMC genomics2024

Computational deconvolution of cell type-specific gene expression in COPD and IPF lungs reveals disease severity associations.

Min Hyung Ryu, Jeong H Yun, Kangjin Kim, Michele Gentili, Auyon Ghosh, Frank Sciurba, Lucas Barwick, Andrew Limper, Gerard Criner, Kevin K Brown and 9 more

Abstract read
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Pilot study ofRespiratory research · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Min Hyung RyuChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Jeong H YunChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Kangjin KimChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Michele GentiliChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Auyon GhoshDepartment of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, USA.
Frank SciurbaDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Lucas BarwickEmmes, Frederick, MD, USA.
Andrew LimperDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Gerard CrinerThoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Kevin K BrownDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Robert WiseDepartment of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.
Fernando J MartinezDepartment of Medicine, Weill Cornell Medical College, NYPresbyterian Hospital, New York, NY, USA.
Kevin R FlahertyDivision of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
Michael H ChoChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Peter J CastaldiChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Dawn L DeMeoChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Edwin K SilvermanChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.
Craig P Hersh *Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA. craig.hersh@channing.harvard.edu.
Jarrett D Morrow *Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA, 181 Longwood Ave, 02115, MA.

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Studies of Rare Genetic Variation in the Isolated Population of SardiniaR01HL117626 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABECASIS, GONCALO · 2013 to 2016
$10.5M
Rare variants and NHLBI traits in deeply phenotyped cohortsR01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2014 to 2016
$8.9M
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and GeneticsR01HL133135 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORITZ, ROBERT L, SILVERMAN, EDWIN K · 2017 to 2025
$7.2M
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTLR01HL124233 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASTALDI, PETER · 2014 to 2024
$7.1M
Rare variants and NHLBI traits in deeply phenotyped cohortsU01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2017 to 2018
$5.6M
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatmentR01HL166231 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAIG P HERSH · 2023 to 2026
$3.3M
Uncovering the genetically-driven differential susceptibility to chronic obstructive pulmonary disease and pulmonary fibrosisR01HL162813 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL H. CHO · 2023 to 2026
$3.1M
Genetic variants that affect the airway epithelium to drive obstructive lung diseaseR01HL166992 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter Castaldi, Yohannes Tesfaigzi · 2024 to 2026
$2.6M
COPD GWAS Functional Variant Identification in Airway Epithelial Cells using Deep Learning Splicing ModelsR01HL171213 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter Castaldi, Yohannes Tesfaigzi · 2024 to 2026
$2.3M
Integrative omics pipeline to identify novel COPD genes and pathwaysK25HL136846 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORROW, JARRETT · 2017 to 2021
$945k
The role of COPD genetic risk factor HHIP on lymphocytic inflammationK08HL146972 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI YUN, JEONG H · 2020 to 2024
$848k
Alpha-1 Foundation Research GrantCIHR FRN:194027NHLBI NIH HHS HHSN268201800001CNHLBI NIH HHS K08 HL146972NHLBI NIH HHS K25 HL136846NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL117626NHLBI NIH HHS R01 HL120393NHLBI NIH HHS R01 HL124233NHLBI NIH HHS R01 HL133135NHLBI NIH HHS R01HL133135NHLBI NIH HHS R01 HL162813NHLBI NIH HHS R01HL162813NHLBI NIH HHS R01 HL166231NHLBI NIH HHS R01HL166231NHLBI NIH HHS R01 HL166992NHLBI NIH HHS R01 HL171213NHLBI NIH HHS U01 HL120393NIEHS NIH HHS HHSN268201600032CTOPMed Fellowship
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are debilitating diseases associated with divergent histopathological changes in the lungs. At present, due to cost and technical limitations, profiling cell types is not practical in large epidemiology cohorts (n > 1000). Here, we used computational deconvolution to identify cell types in COPD and IPF lungs whose abundances and cell type-specific gene expression are associated with disease diagnosis and severity.

resultsWe analyzed lung tissue RNA-seq data from 1026 subjects (COPD, n = 465; IPF, n = 213; control, n = 348) from the Lung Tissue Research Consortium. We performed RNA-seq deconvolution, querying thirty-eight discrete cell-type varieties in the lungs. We tested whether deconvoluted cell-type abundance and cell type-specific gene expression were associated with disease severity. The abundance score of twenty cell types significantly differed between IPF and control lungs. In IPF subjects, eleven and nine cell types were significantly associated with forced vital capacity (FVC) and diffusing capacity for carbon monoxide (D

conclusionsUtilization of RNA-seq deconvolution enabled us to pinpoint cell types present in the lungs that are associated with the severity of COPD and IPF. This knowledge offers valuable insight into the alterations within tissues in more advanced illness, ultimately providing a better understanding of the underlying pathological processes that drive disease progression.

Indexed as

Idiopathic Pulmonary FibrosisLungPulmonary Disease, Chronic ObstructiveSeverity of Illness IndexAgedComputational BiologyFemaleGene Expression ProfilingHumansMaleMiddle AgedCell type-specific gene expression.Chronic obstructive pulmonary diseaseComputational deconvolutionIdiopathic pulmonary fibrosisLung function testsRNA sequencing

Identifiers

PMID39695952
PMCPMC11654147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.